BLOG POST

Rotarix licensed in Singapore

By
November 17, 2005

Singapore has licensed GSK's new vaccine against rotavirus gastroenteritis among children under 5 years old. The vaccine was tested in 11 polyclinics and three hospitals in Singapore. Rotavirus gastroenteritis is a viral infection which causes severe diarrhea and kills half a million children worldwide every year.This is apparently the first time that a major pharmaceutical company has conducted large scale vaccine trials licensed the vaccine licensed in Singapore before introducing it in the United States or Europe.

DISCLAIMER & PERMISSIONS

CGD's publications reflect the views of the authors, drawing on prior research and experience in their areas of expertise. CGD is a nonpartisan, independent organization and does not take institutional positions. You may use and disseminate CGD's publications under these conditions.

More Reading

Pharmaceutical manufacture background with glass bottles with clear liquid on automatic conveyor line.
Blog Post

Global Vaccine Security Still Needs International Cooperation: Are Middle Powers the Key?

William Savedoff
March 24, 2026
Doctor prepares a vaccine
POLICY PAPER

What Role Can Routine Vaccination Play in Pandemic Prevention and Preparedness?

Tim Laurence et al.
February 23, 2026
Just opened vial with liquid drug as vaccine ready dose flu shot
Blog Post

The US Just Changed Vaccine Guidance. Can AI Help Families Decide?

Leah R. Rosenzweig
January 13, 2026
CGD Podcast (logo)
Blog Post

CGD Podcast: Vaccines in a Changing Global Health Landscape

Rachel Glennerster
January 08, 2026